NEW YORK (GenomeWeb News) –GeneGo said today that Proteostasis Therapeutics has licensed its MetaCore curated data mining and analysis platform.

Proteostasis Therapeutics is developing small molecule therapeutics based on studies of the human proteostasis network, the balance of proteins that can protect the body from diseases, GeneGo said. Deficiencies in that network can lead to a range of diseases, such as emphysema, type II diabetes, Alzheimer's disease, and Huntington's disease, said GeneGo.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.